Latest edition of the Journal of Neuromuscular Diseases now online – Apr 2020

A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:

Journal of Neuromuscular Diseases: Volume 7, issue 2

 

*Hanns is joint editor in chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.

 

Articles:

  • Pseudoexons of the DMD gene
  • Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2
  • Relationship between eating and digestive symptoms and respiratory function in advanced Duchenne muscular dystrophy patients
  • Infants diagnosed with spinal muscular atrophy and 4 SMN2 copies through newborn screening – Opportunity or burden?
  • Upregulation of hallmark muscle genes protects Gne M743T/M743T mutated knock-in mice from kidney and muscle phenotype
  • Clinical and genetic features in a series of eight unrelated patients with neuropathy due to Glycyl-tRNA Synthetase (GARS) variants
  • RESTORE: A prospective multinational registry of patients with genetically confirmed spinal muscular atrophy – Rationale and study design
  • Improved criteria for the classification of titin variants in inherited skeletal myopathies
  • Characterizing enrollment in observational studies of Duchenne muscular dystrophy by race and ethnicity
  • The slipping slipper sign: A poor man’s test for severe diabetic peripheral neuropathy
  • Scoliosis surgery significantly impacts motor abilities in higher-functioning individuals with spinal muscular atrophy
  • Paramyotonia congenita with persistent distal and facial muscle weakness: A case report with literature review
Journal of Neuromuscular Diseases

Read next...

New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...
New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.

Drs Hanns Lochmüller and Mireille Khacho New Leaders of University of Ottawa Eric Poulin Centre for Neuromuscular Disease

We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (uOBMRI)! Drs. Hanns Lochmüller and Mireille Khacho have been appointed...
Dr Lola Lessard and Kelly Ho receive prestigious research poster awards

Lab Members Receive Research Poster Awards at National and International Conferences

Kelly Ho Receives Poster Award at World Muscle Society Congress Congratulations to PhD researcher Kelly Ho, whose poster presentation "Investigating muscle specific kinase antibody treatment...